Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 22292598)

1.

The role of nebulized therapy in the management of COPD: evidence and recommendations.

Dhand R, Dolovich M, Chipps B, Myers TR, Restrepo R, Farrar JR.

COPD. 2012 Feb;9(1):58-72. doi: 10.3109/15412555.2011.630047. Review.

PMID:
22292598
2.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

3.

Inhalatory therapy training: a priority challenge for the physician.

Melani AS.

Acta Biomed. 2007 Dec;78(3):233-45. Review.

PMID:
18330086
4.

Practical problems with aerosol therapy in COPD.

Rau JL.

Respir Care. 2006 Feb;51(2):158-72. Review.

5.

Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease.

Barrons R, Pegram A, Borries A.

Am J Health Syst Pharm. 2011 Jul 1;68(13):1221-32. doi: 10.2146/ajhp100452. Review.

PMID:
21690428
6.
7.

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology.

Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, Smaldone GC, Guyatt G; American College of Chest Physicians; American College of Asthma, Allergy, and Immunology.

Chest. 2005 Jan;127(1):335-71. Review.

PMID:
15654001
8.
9.

Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.

Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, Corrigan C, Levy M, Crompton GK.

Respir Med. 2008 Apr;102(4):593-604. Epub 2007 Dec 20. Review.

10.

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.

Hodder R, Price D.

Int J Chron Obstruct Pulmon Dis. 2009;4:381-90. Epub 2009 Oct 19. Review.

11.

Importance of inhaler devices in the management of airway disease.

Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, Barnes PJ.

Respir Med. 2008 Jan;102(1):10-9. Epub 2007 Oct 17. Review.

12.

Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.

Aggarwal B, Gogtay J.

Expert Rev Respir Med. 2014 Jun;8(3):349-56. doi: 10.1586/17476348.2014.905916. Epub 2014 May 7. Review.

PMID:
24802511
13.

Customizing inhaled therapy to meet the needs of COPD patients.

Fromer L, Goodwin E, Walsh J.

Postgrad Med. 2010 Mar;122(2):83-93. doi: 10.3810/pgm.2010.03.2125. Review.

PMID:
20203459
14.

Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.

Ram FS, Brocklebank DM, Muers M, Wright J, Jones PW.

Cochrane Database Syst Rev. 2002;(1):CD002170. Review.

PMID:
11869627
15.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
16.

Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.

Geller DE.

Respir Care. 2005 Oct;50(10):1313-21; discussion 1321-2. Review.

17.

Novolizer: how does it fit into inhalation therapy?

Magnussen H.

Curr Med Res Opin. 2005;21 Suppl 4:S39-46; discussion S47.

PMID:
16138944
18.

Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease.

Scott LJ.

Drugs. 2012 Feb 12;72(3):395-414. doi: 10.2165/11208460-000000000-00000. Review.

PMID:
22316354
20.

Qualitative assessment of attributes and ease of use of the ELLIPTAâ„¢ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.

Svedsater H, Dale P, Garrill K, Walker R, Woepse MW.

BMC Pulm Med. 2013 Dec 7;13:72. doi: 10.1186/1471-2466-13-72.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk